Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Lang

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|March 25, 2010
Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertensionIrene Lang
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Chronic thromboembolic pulmonary hypertension: a distinct disease entityIrene Lang
BMJ (Clinical Research Ed.)|May 24, 2003
Cardiovascular managementIrene Lang
Pulmonary Circulation|January 9, 2018
Targeting inflammation and immunity in pulmonary arterial hypertension: any easier after the CANTOS proof-of-concept that anti-inflammation cuts cardiovascular events?Christian Gerges, Irene Lang
Proceedings of the American Thoracic Society|September 12, 2006
Risk factors for chronic thromboembolic pulmonary hypertensionIrene Lang, Kim Kerr
International Journal of Cardiology|May 17, 2021
A multiparametric approach for the assessment of prognosis in pulmonary hypertension after pulmonary endarterectomy - stratifying risk in a poorly-defined conditionChristian Gerges, Irene Lang
Expert Opinion on Pharmacotherapy|February 24, 2012
Tadalafil for the treatment of pulmonary arterial hypertensionMaria Klara Frey, Irene Lang
Expert Review of Cardiovascular Therapy|November 4, 2014
Extended-release oral treprostinil for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|May 14, 2008
Treprostinil for the treatment of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 12, 2008
The role of treprostinil in the management of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|March 25, 2010
Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertensionIrene Lang
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Chronic thromboembolic pulmonary hypertension: a distinct disease entityIrene Lang
BMJ (Clinical Research Ed.)|May 24, 2003
Cardiovascular managementIrene Lang
Pulmonary Circulation|January 9, 2018
Targeting inflammation and immunity in pulmonary arterial hypertension: any easier after the CANTOS proof-of-concept that anti-inflammation cuts cardiovascular events?Christian Gerges, Irene Lang
Proceedings of the American Thoracic Society|September 12, 2006
Risk factors for chronic thromboembolic pulmonary hypertensionIrene Lang, Kim Kerr
International Journal of Cardiology|May 17, 2021
A multiparametric approach for the assessment of prognosis in pulmonary hypertension after pulmonary endarterectomy - stratifying risk in a poorly-defined conditionChristian Gerges, Irene Lang
Expert Opinion on Pharmacotherapy|February 24, 2012
Tadalafil for the treatment of pulmonary arterial hypertensionMaria Klara Frey, Irene Lang
Expert Review of Cardiovascular Therapy|November 4, 2014
Extended-release oral treprostinil for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|May 14, 2008
Treprostinil for the treatment of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 12, 2008
The role of treprostinil in the management of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
Pageof 16